search

Active clinical trials for "Conjunctivitis, Allergic"

Results 151-160 of 209

Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis

ConjunctivitisAllergic

The objective of this study is to evaluate the dose response, and efficacy of Mapracorat ophthalmic formulation compared to its vehicle for the prevention of symptoms and signs associated with allergic conjunctivitis using a conjunctival allergen challenge (CAC) model.

Completed10 enrollment criteria

Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment

Vernal Keratoconjunctivitis

This interventional study aims to evaluate the efficacy of oral administration of Lactobacillus Rhamnosus GG in preventing relapses of ocular inflammation in Vernal Keratoconjunctivitis (VKC) patients.

Completed6 enrollment criteria

Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model

Chronic Allergic Conjunctivitis

The purpose of this study is to evaluate the effectiveness of the modified Conjunctival Allergen Challenge (CAC) and observe how the produced allergic inflammation reacts to treatment with a proven ocular anti-inflammatory medication, Prednisolone, assessed by the following measures: Chronic Allergic Inflammation assessed using confocal microscopy Ocular itching Conjunctival redness

Completed11 enrollment criteria

To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival...

Allergic Conjunctivitis

The purpose of the study is to determine whether Al38583 Ophthalmic Solution is safe and effective in reducing tear eosinophil levels at 5-8 hours after Conjunctival Allergen Challenge (CAC).

Withdrawn2 enrollment criteria

Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis

Ocular ItchingOcular Allergy4 more

The purpose of this study is to evaluate the efficacy and safety of four doses of PRO-118 ophthalmic solution ophthalmic solution compared with placebo, for the treatment of seasonal (SAC) and perennial (PAC) allergic conjunctivitis.

Withdrawn20 enrollment criteria

Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

The purpose of this study was to evaluate the efficacy of Maxidex and Patanol compared to placebo in patients with allergic conjunctivitis when exposed to controlled allergen levels in an Environmental Exposure Chamber (EEC).

Completed10 enrollment criteria

Comparison of CL Wear Between Two Allergy Drops

Allergic Conjunctivitis

Comparison of two allergy drops for enhancing comfort and performance of contact lens wear

Withdrawn7 enrollment criteria

Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan...

Allergic Conjunctivitis

Intravenous- injection of beta-1,3-glucan in human is known to induce T helper type 1 response, while oral uptake did not. It was examined whether superfine dispersed beta-1,3-glucan (SDG) contrived to absorbed by intestinal mucosa would alleviate allergic symptoms by per-oral ingestion

Terminated4 enrollment criteria

Manuka Eye Droops for Treatment of Allergy

Allergic Conjunctivitis

Manuka honey eye drops are used for dry eyes and blepharitis. Manuka honey has been proven to be useful for eczema, atopic dermatitis, wound healing, anti-bacterial, anti-parasitic and anti-inflammatory actions.

Withdrawn29 enrollment criteria

A Six-Week Safety Study of an Investigational Ophthalmic Solution

Allergic Conjunctivitis

The purpose of this study was to evaluate the ocular safety of an investigational ophthalmic solution in subjects 2 years of age and older with asymptomatic eyes when administered once daily in both eyes for up to 6 weeks.

Completed20 enrollment criteria
1...151617...21

Need Help? Contact our team!


We'll reach out to this number within 24 hrs